|
Name |
Preussilide B
|
Molecular Formula | C25H34O4 | |
IUPAC Name* |
(2E,4E,6E)-7-[(1R,6R,7R,8S,8aS)-7-hydroxy-3,6,8-trimethyl-2-(2-oxopropyl)-1,5,6,7,8,8a-hexahydronaphthalen-1-yl]-4,6-dimethylhepta-2,4,6-trienoic acid
|
|
SMILES |
C[C@@H]1CC2=CC(=C([C@@H]([C@H]2[C@@H]([C@@H]1O)C)/C=C(\C)/C=C(\C)/C=C/C(=O)O)CC(=O)C)C
|
|
InChI |
InChI=1S/C25H34O4/c1-14(7-8-23(27)28)9-15(2)10-22-21(13-18(5)26)16(3)11-20-12-17(4)25(29)19(6)24(20)22/h7-11,17,19,22,24-25,29H,12-13H2,1-6H3,(H,27,28)/b8-7+,14-9+,15-10+/t17-,19+,22+,24+,25-/m1/s1
|
|
InChIKey |
WPOOLKYXEKIQSJ-FKYFWVDISA-N
|
|
Synonyms |
Preussilide B; CHEMBL4128814; J3.662.981I
|
|
CAS | NA | |
PubChem CID | 132489953 | |
ChEMBL ID | CHEMBL4128814 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 398.5 | ALogp: | 3.9 |
HBD: | 2 | HBA: | 4 |
Rotatable Bonds: | 6 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 74.6 | Aromatic Rings: | 2 |
Heavy Atoms: | 29 | QED Weighted: | 0.466 |
Caco-2 Permeability: | -5.032 | MDCK Permeability: | 0.00002880 |
Pgp-inhibitor: | 0.004 | Pgp-substrate: | 0.061 |
Human Intestinal Absorption (HIA): | 0.479 | 20% Bioavailability (F20%): | 0.57 |
30% Bioavailability (F30%): | 0.003 |
Blood-Brain-Barrier Penetration (BBB): | 0.011 | Plasma Protein Binding (PPB): | 96.88% |
Volume Distribution (VD): | 1.557 | Fu: | 3.44% |
CYP1A2-inhibitor: | 0.119 | CYP1A2-substrate: | 0.114 |
CYP2C19-inhibitor: | 0.074 | CYP2C19-substrate: | 0.808 |
CYP2C9-inhibitor: | 0.463 | CYP2C9-substrate: | 0.862 |
CYP2D6-inhibitor: | 0.017 | CYP2D6-substrate: | 0.106 |
CYP3A4-inhibitor: | 0.102 | CYP3A4-substrate: | 0.465 |
Clearance (CL): | 1.337 | Half-life (T1/2): | 0.921 |
hERG Blockers: | 0.008 | Human Hepatotoxicity (H-HT): | 0.345 |
Drug-inuced Liver Injury (DILI): | 0.057 | AMES Toxicity: | 0.04 |
Rat Oral Acute Toxicity: | 0.59 | Maximum Recommended Daily Dose: | 0.901 |
Skin Sensitization: | 0.883 | Carcinogencity: | 0.492 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.01 |
Respiratory Toxicity: | 0.976 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003387 | 0.750 | D05QDC | 0.282 | ||||
ENC003386 | 0.750 | D0G3PI | 0.271 | ||||
ENC003389 | 0.635 | D02DGU | 0.271 | ||||
ENC003384 | 0.621 | D00DKK | 0.271 | ||||
ENC003388 | 0.524 | D0B1IP | 0.246 | ||||
ENC003852 | 0.337 | D0E9KA | 0.223 | ||||
ENC003167 | 0.302 | D0X7XG | 0.222 | ||||
ENC003854 | 0.300 | D0W2EK | 0.213 | ||||
ENC003853 | 0.300 | D0FG6M | 0.209 | ||||
ENC002015 | 0.279 | D0S7WX | 0.207 |